학술논문

Vemurafenib in patients with BRAFV600 mutation-positive metastatic melanoma: final overall survival results of the randomized BRIM-3 study
Document Type
Article
Source
In Annals of Oncology October 2017 28(10):2581-2587
Subject
Language
ISSN
0923-7534